Notice
25 Aug 2025
public meeting, fda, pharmaceutical, hiring, drug regulation, user fee, biosimilars, retention
💊FDA Announces Public Meeting on Drug User Fee Act and Hiring Assessment
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled "Prescription Drug User Fee Act and Biosimilar User Fee Amendments Hiring and Retention Assessment." The topic to be discussed is a hiring and retention assessment which was performed by an independent contractor.
Learn More